Results 61 to 70 of about 84,926 (204)

Myricetin, the main flavonoid in Syzygium cumini leaf, is a novel inhibitor of platelet thiol isomerases PDI and ERp5 [PDF]

, 2020
Background: Flavonoids have been characterized as a prominent class of compounds to treat thrombotic diseases through the inhibition of thiol isomerases. Syzygium cumini is a flavonoid-rich medicinal plant that contains myricetin and gallic acid.
Ayyanar, Banno, Bekendam, Bi, Chagas, Chagas, Chang, Chen, Chung, Dang, De Bona, Dutta-Roy, Essex, Essex, Essex, Ghoshal, Giamogante, Giamogante, Holbrook, Inoue, Jarvis, Jasuja, Jayakumar, Jordan, Kang, Kehrel, Kim, Lahav, Lakowicz, Lescano, Lin, Lu, Mangin, Masuda, Navarro-Nuñez, Park, Raffaelli, Raturi, Sharma, Sousa, Stopa, Taylor, Trnkova, Wang, Ware, Wendelboe   +45 more
core   +1 more source

THE ROLE OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER THE EMERGENCE OF MORE POWERFUL INHIBITORS OF P2Y12 RECEPTOR

Klinicist, 2014
The role of P2Y12 receptor blocker clopidogrel after the introduction into clinical practice of new, more powerful and stable operating drugs belonging to this class of antiplatelet agents is discussed.
S. R. Gilyarevsky, A. G. Larin, P. Y. Lopotovsky, I. M. Kuzmina, O. V. Baturina   +4 more
doaj   +3 more sources

Prescription of secondary preventive drugs after ischemic stroke: results from the Malaysian National Stroke Registry

BMC Neurology, 2017
Background Evaluation of secondary stroke prevention in low and middle-income countries remains limited. This study assessed the prescription of secondary preventive drugs among ischemic stroke patients upon hospital discharge in Malaysia and identified ...
Wen Yea Hwong, Zariah Abdul Aziz, Norsima Nazifah Sidek, Michiel L. Bots, Sharmini Selvarajah, L. Jaap Kappelle, Sheamini Sivasampu, Ilonca Vaartjes   +7 more
doaj   +1 more source

(249) DO ANTIPLATELET DRUGS USE CONTRIBUTE TO CLINICAL OUTCOMES IN PATIENTS RECEIVING PENILE LOW-INTENSITY SHOCK WAVE THERAPY (LI-SWT) FOR ERECTILE DYSFUNCTION? [PDF]

, 2023
Geyik Dr. Serdar, Deger Dr. Mutlu, Akdogan Dr. Nebil, Kankilic Dr. Nazim A, Yilmaz Dr. Ismail O, Aridogan Prof. Ibrahim A   +5 more
openalex   +1 more source

Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research. [PDF]

, 2017
Acute ischemic stroke is a devastating cause of death and disability, consequences of which depend on the time from ischemia onset to treatment, the affected brain region, and its size.
Akyol, Onat, Applegate, Richard, Araujo, Camila, Ho, Wing Mann, Huang, Lei, Reis, Cesar, Zhang, John H   +6 more
core   +3 more sources

Protocol for the effective feedback to improve primary care prescribing safety (EFIPPS) study : a cluster randomised controlled trial using ePrescribing data [PDF]

, 2012
High-risk prescribing in primary care is common and causes considerable harm. Feedback interventions to improve care are attractive because they are relatively cheap to widely implement. There is good evidence that feedback has small to moderate effects,
Barnett, Karen, Bennie, Marion, Guthrie, Bruce, Petrie, Dennis, Ritchie, Lewis, Robertson, Chris, Treweek, S.   +6 more
core   +2 more sources

The study of price situation on the domestic antiplatelet market

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2017
Complex therapy of cardiovascular diseases and their prophylaxis include antiplatelet administration. Considering that in most cases patients with cardiovascular diseases need antiplatelet administration during long time, social and economic availability
Ye. А. Redkina, N. А. Tkachenko, V. V. Gladyshev, I. A. Pukhalskaya   +3 more
doaj   +1 more source

ABC of arterial and venous disease. Secondary prevention of transient ischaemic attack and stroke [PDF]

, 2000
No abstract ...
Bath, P.M.W., Lees, K.R., Naylor, A.R.
core   +1 more source

Antiplatelet Therapy in the Patient with Coronary Stent Undergoing Surgery and Dental Procedure

Journal of Health Science and Medical Research (JHSMR), 2011
Antiplatelet drugs are recommended for patients with coronary artery disease, especially if the patient has a coronary stent implantation. Premature discontinuation of antiplatelet drugs either by the patient or medical personnel is the most important ...
Noppadol Chamnarnphol
doaj  

Continuing versus discontinuing antiplatelet drugs, vasodilators, and/or cerebral ameliorators on perioperative total blood loss in total knee arthroplasty without pneumatic tourniquet

Arthroplasty Today, 2018
Background: Although studies have supported the utility of perioperative continuation of antiplatelet drugs, vasodilators, and cerebral ameliorators in most procedures, no study compared total volume of blood loss after total knee arthroplasty (TKA) in ...
Sachiyuki Tsukada, MD, Motohiro Wakui, MD   +1 more
doaj   +1 more source